Question 1 · Medium
A 30-year-old woman with sickle cell disease has monthly red cell transfusions and type 2 diabetes. Why is her HbA1c an unreliable measure of glucose control?
- AHydroxyurea raises the glucose in the sample
- BSickle cells take up glucose after sampling
- CTransfused and short-lived red cells distort HbA1c
- DHer diabetes is too recent for HbA1c to rise
Show answerHide answer
Answer: C · Transfused and short-lived red cells distort HbA1c
HbA1c depends on how long red cells have been exposed to glucose, so anything that shortens red cell survival or replaces cells gives a falsely low result. Haemolysis, sickle cell disease, thalassaemia and recent transfusion all do this, and some HbA1c methods are affected by haemoglobin variants. These conditions are common in Gulf populations. Capillary glucose profiles, continuous glucose monitoring or fructosamine are used instead.
- A: Hydroxyurea does not raise measured glucose in the sample.
- B: Glucose use by cells after sampling lowers plasma glucose, not HbA1c.
- D: HbA1c can be used soon after diagnosis; the problem is red cell turnover.